WALL PROTECTION AND IPS UNITS
Cladding and IPS specialist’s positive future outlook
BioClad, which manufactures and supplies bespoke IPS units, and also supplies hygienic and antimicrobial cladding to the healthcare, pharma, education, retail, hospitality, and commercial sectors, has established its first in-house IPS manufacturing unit in a new York facility, and – to ensure a more efficient supply – brought under one roof distribution of its wall cladding at a new Harrogate depot. As HEJ editor, Jonathan Baillie, discovered from Sales director, Claire Redhead, the business is looking ahead with renewed confidence.
BioClad was established in 2008 as a company in its own right by Lindsay McKenzie, the current CEO. At the time its main focus was supplying ‘hygienic’ wall cladding to customers throughout the UK and Ireland. Today this is still a key part of its activities, but to its product range it has since added antimicrobial wall cladding, integrated plumbing systems (IPS units, for short), antimicrobial safety flooring, antimicrobial heavy-duty doors, and antimicrobial wall and door protection worldwide. As you would expect given that its wall cladding systems are heavily targeted at healthcare facilities, among the cladding’s key properties are ease of installation and cleaning, chemical resistance, and a robust construction. Prior to concluding a ‘partnership’
agreement with BioCote – which has been established as a supplier of antimicrobial silver-ion technology supplier for over 25 years – and with which BioClad has a licence to embed the company’s silver- ion additives into its wall cladding during manufacture, Lindsay McKenzie had run a separate business supplying more ‘standard’ PVC cladding since 1995. The BioClad website states that the integration of BioCote silver-ion technology into products and surfaces during manufacture provides ‘integral protection’ against microbes including MRSA and E. coli, even ‘deactivating’ Influenza H1N1 by up to 99.99% within 24 hours. Laboratory tests and real-life studies have verified that the technology, which ‘works 24-hours-a- day’, eradicates 80% of microbes within 15 minutes, and ‘up to 99.99%’ within two hours.
Simplifying cleaning and maintenance With the ever-greater focus on hygiene and infection control in healthcare, BioClad says these properties not only help minimise cross-contamination, but also simplify maintenance and cleaning of a range of surfaces and products found in medical environments without the use of harsh chemicals. Once integrated, the
A brightly coloured BioPod IPS unit through a suspended ceiling.
additives will continue to function as a long-term defence against microbes in the treated product or coating. By way of context, BioClad explains
that while antibacterial technologies are only effective against bacteria, an antimicrobial combats a wide spectrum of microbes – including bacteria, mould, fungi, and even viruses. Currently, there are four main types of antimicrobial additive in widespread use – based on silver-ion (as in the case of BioCote additives), copper, zinc, and organic technologies. The silver-ion additives reportedly kill even antibiotic-resistant strains of bacteria such as MRSA, VRE, and CRE, but also mould such as Aspergillus which, in addition to
being unsightly and unpleasant, presents a considerable health hazard to those exposed to it. The technology destroys the microbes by damaging the proteins on which they rely to exist, and the cell membrane – causing oxidative damage, interfering with DNA replication, and promoting the formation of reactive oxygen species.
‘Hygienic’ cladding Alongside its antimicrobial wall cladding, BioClad also supplies what it dubs its ‘hygienic’ PVC cladding – based on a standard white wall panel compatible with standard trims and details. The ‘advanced’ PVC hygienic cladding panels
February 2023 Health Estate Journal 55
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
